This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Abbvie Inc.. Active years: 2014.
Company Filing History:
Years Active: 2014
Title: Eileen Belanger: Innovator in Prostaglandin Research
Introduction
Eileen Belanger is a notable inventor based in Northbridge, MA (US). She has made significant contributions to the field of biomedical research, particularly in the area of prostaglandin binding proteins. Her work has implications for various medical conditions where prostaglandin E activity is detrimental.
Latest Patents
Eileen holds a patent for "Prostaglandin E2 binding proteins and uses thereof." This invention encompasses prostaglandin E (PGE) binding proteins and relates to antibodies that are wild-type, chimeric, CDR grafted, and humanized. The preferred antibodies exhibit high affinity for prostaglandin E and are capable of neutralizing prostaglandin E activity both in vitro and in vivo. The patent also details methods for making and using these antibodies, which are useful for detecting prostaglandin E and inhibiting its activity in human subjects suffering from related disorders.
Career Highlights
Eileen is currently associated with AbbVie Inc., where she continues her research and development efforts. Her innovative work has positioned her as a key figure in her field, contributing to advancements in therapeutic applications.
Collaborations
Eileen collaborates with esteemed colleagues, including Jjijie Gu and Charles W. Hutchins. These partnerships enhance the research and development process, fostering innovation and discovery in the biomedical sector.
Conclusion
Eileen Belanger's contributions to prostaglandin research exemplify the impact of innovative thinking in medicine. Her patent and ongoing work at AbbVie Inc. highlight her role as a leading inventor in the field.